GDRX
Goodrx Holdings Inc
Price:  
2.05 
USD
Volume:  
859,359.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GDRX WACC - Weighted Average Cost of Capital

The WACC of Goodrx Holdings Inc (GDRX) is 7.6%.

The Cost of Equity of Goodrx Holdings Inc (GDRX) is 9.20%.
The Cost of Debt of Goodrx Holdings Inc (GDRX) is 7.35%.

Range Selected
Cost of equity 7.80% - 10.60% 9.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.20% - 7.50% 7.35%
WACC 6.8% - 8.5% 7.6%
WACC

GDRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.85 1.02
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.80% 10.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.7 0.7
Cost of debt 7.20% 7.50%
After-tax WACC 6.8% 8.5%
Selected WACC 7.6%

GDRX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for GDRX:

cost_of_equity (9.20%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.85) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.